Biogen Inc (BIIB)
217.51
+4.00
(+1.87%)
USD |
NASDAQ |
May 03, 16:00
218.88
+1.37
(+0.63%)
After-Hours: 20:00
Biogen Gross Profit (Quarterly): 1.748B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.748B |
December 31, 2023 | 1.768B |
September 30, 2023 | 1.871B |
June 30, 2023 | 1.863B |
March 31, 2023 | 1.800B |
December 31, 2022 | 1.973B |
September 30, 2022 | 2.039B |
June 30, 2022 | 2.105B |
March 31, 2022 | 1.778B |
December 31, 2021 | 2.074B |
September 30, 2021 | 2.267B |
June 30, 2021 | 2.315B |
March 31, 2021 | 2.216B |
December 31, 2020 | 2.362B |
September 30, 2020 | 2.927B |
June 30, 2020 | 3.270B |
March 31, 2020 | 3.08B |
December 31, 2019 | 3.224B |
September 30, 2019 | 3.170B |
June 30, 2019 | 3.140B |
March 31, 2019 | 2.888B |
December 31, 2018 | 3.038B |
September 30, 2018 | 2.978B |
June 30, 2018 | 2.936B |
March 31, 2018 | 2.685B |
Date | Value |
---|---|
December 31, 2017 | 2.798B |
September 30, 2017 | 2.708B |
June 30, 2017 | 2.712B |
March 31, 2017 | 2.426B |
December 31, 2016 | 2.494B |
September 30, 2016 | 2.539B |
June 30, 2016 | 2.524B |
March 31, 2016 | 2.414B |
December 31, 2015 | 2.508B |
September 30, 2015 | 2.468B |
June 30, 2015 | 2.306B |
March 31, 2015 | 2.242B |
December 31, 2014 | 2.343B |
September 30, 2014 | 2.209B |
June 30, 2014 | 2.130B |
March 31, 2014 | 1.851B |
December 31, 2013 | 1.707B |
September 30, 2013 | 1.593B |
June 30, 2013 | 1.493B |
March 31, 2013 | 1.281B |
December 31, 2012 | 1.284B |
September 30, 2012 | 1.246B |
June 30, 2012 | 1.282B |
March 31, 2012 | 1.159B |
December 31, 2011 | 1.926B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.748B
Minimum
Mar 2024
3.270B
Maximum
Jun 2020
2.350B
Average
2.160B
Median
Gross Profit (Quarterly) Benchmarks
Eli Lilly and Co | 7.094B |
Bristol-Myers Squibb Co | 8.933B |
Gilead Sciences Inc | 5.134B |
AbbVie Inc | 8.216B |
Sage Therapeutics Inc | 6.633M |